Tomorrow, I’m entering a position in Pfizer Inc. (NYSE: PFE)—a globally recognized pharmaceutical giant with strong fundamentals and an attractive technical setup.
Pfizer maintains a solid revenue base, reporting $62.46 billion in total revenue in the last fiscal year. Despite recent fluctuations, its profitability remains intact, with a gross profit of $45.15 billion. The company continues to invest in drug innovation and strategic acquisitions, ensuring long-term growth.
Pfizer is a consistent dividend payer, making it an attractive choice for income-focused investors. Its dividend yield remains competitive, reinforcing its appeal as a long-term hold.
I see strong upside potential — both technically and fundamentally. Now is the perfect time to enter.
交易开始
I bought 200 shares today (225 total) and I bought 10 options!
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。